Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores

被引:39
作者
Knapp, Andrea Caroline [1 ]
Todesco, Liliane [1 ]
Beier, Konstantin [2 ]
Terracciano, Luigi [3 ]
Saegesser, Hans [4 ]
Reichen, Juerg [4 ]
Kraehenbuehl, Stephan [1 ]
机构
[1] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
[2] Univ Basel, Inst Anat & Embryol, Basel, Switzerland
[3] Univ Basel, Inst Pathol, Basel, Switzerland
[4] Univ Bern, Inst Clin Pharmacol, Bern, Switzerland
关键词
D O I
10.1124/jpet.107.131185
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate whether a decrease in carnitine body stores is a risk factor for valproic acid (VPA)-associated hepatotoxicity and to explore the effects of VPA on carnitine homeostasis in mice with decreased carnitine body stores. Therefore, heterozygous juvenile visceral steatosis (jvs)(+/-) mice, an animal model with decreased carnitine stores caused by impaired renal reabsorption of carnitine, and the corresponding wild-type mice were treated with subtoxic oral doses of VPA (0.1 g/g b. wt./day) for 2 weeks. In jvs(+/-) mice, but not in wild-type mice, treatment with VPA was associated with the increased plasma activity of aspartate aminotransferase and alkaline phosphatase. Furthermore, jvs(+/-) mice revealed reduced palmitate metabolism assessed in vivo and microvesicular steatosis of the liver. The creatine kinase activity was not affected by treatment with VPA. In liver mitochondria isolated from mice that were treated with VPA, oxidative metabolism of L-glutamate, succinate, and palmitate, as well as beta-oxidation of palmitate, were decreased compared to vehicle-treated wild-type mice or jvs(+/-) mice. In comparison to vehicle-treated wild-type mice, vehicle-treated jvs(+/-) mice had decreased carnitine plasma and tissue levels. Treatment with VPA was associated with an additional decrease in carnitine plasma (wildtype mice and jvs(+/-) mice) and tissue levels (jvs(+/-) mice) and a shift of the carnitine pools toward short-chain acylcarnitines. We conclude that jvs(+/-) mice reveal a more accentuated hepatic toxicity by VPA than the corresponding wildtype mice. Therefore, decreased carnitine body stores can be regarded as a risk factor for hepatotoxicity associated with VPA.
引用
收藏
页码:568 / 575
页数:8
相关论文
共 40 条
  • [1] Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation
    Baldwin, GS
    Abbott, FS
    Nau, H
    [J]. FEBS LETTERS, 1996, 384 (01) : 58 - 60
  • [2] BRASS EP, 1978, J BIOL CHEM, V253, P2688
  • [3] VALPROATE-INDUCED HEPATIC-FAILURE IN A CASE OF CYTOCHROME-C-OXIDASE DEFICIENCY
    CHABROL, B
    MANCINI, J
    CHRETIEN, D
    RUSTIN, P
    MUNNICH, A
    PINSARD, N
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (02) : 133 - 135
  • [4] VALPROIC ACID HEPATIC FATALITIES - A RETROSPECTIVE REVIEW
    DREIFUSS, FE
    SANTILLI, N
    LANGER, DH
    SWEENEY, KP
    MOLINE, KA
    MENANDER, KB
    [J]. NEUROLOGY, 1987, 37 (03) : 379 - 385
  • [5] INHIBITION OF THE MITOCHONDRIAL OXIDATION OF FATTY-ACIDS BY TETRACYCLINE IN MICE AND IN MAN - POSSIBLE ROLE IN MICROVESICULAR STEATOSIS INDUCED BY THIS ANTIBIOTIC
    FRENEAUX, E
    LABBE, G
    LETTERON, P
    DINH, TL
    DEGOTT, C
    GENEVE, J
    LARREY, D
    PESSAYRE, D
    [J]. HEPATOLOGY, 1988, 8 (05) : 1056 - 1062
  • [6] INHIBITION OF MITOCHONDRIAL BETA-OXIDATION AS A MECHANISM OF HEPATOTOXICITY
    FROMENTY, B
    PESSAYRE, D
    [J]. PHARMACOLOGY & THERAPEUTICS, 1995, 67 (01) : 101 - 154
  • [7] HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS
    GONZALEZ, FJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) : 346 - 352
  • [8] GORNALL AG, 1949, J BIOL CHEM, V177, P751
  • [9] GRAM L, 1985, ACTA NEUROL SCAND, V72, P129
  • [10] EFFECTS OF VALPROATE ON BIOGENESIS AND FUNCTION OF LIVER-MITOCHONDRIA
    HAYASAKA, K
    TAKAHASHI, I
    KOBAYASHI, Y
    IINUMA, K
    NARISAWA, K
    TADA, K
    [J]. NEUROLOGY, 1986, 36 (03) : 351 - 356